Citalopram

Basic Citalopram Information

• INN (International Nonproprietary Name): Citalopram
• Brand Names Available In United Kingdom: Cipramil; Citalopram Teva; Sandoz
• ATC Code: N06AB04
• Forms & Dosages: Tablets 10 mg, 20 mg, 40 mg; Oral drops/solution 10 mg/mL and 20 mg/mL.
• Manufacturers In United Kingdom: Teva; Sandoz; Zentiva; Lundbeck (originator).
• Registration Status In United Kingdom: MHRA/EMA-approved prescription medicine for indicated uses.
• OTC / Rx Classification: Prescription only (Rx). Not available over the counter in regulated markets.

Critical Warnings And Restrictions (Safety First)

High-Risk Groups (Elderly, Pregnancy, Chronic Illness)

Worried about safety in older adults, pregnancy or long-term health problems?

Citalopram is the INN and is supplied as tablets (10 mg, 20 mg, 40 mg) and oral drops (10 mg/mL, 20 mg/mL).

Immediate assessment and prescriber or pharmacist counselling is essential before starting citalopram in high-risk UK patients.

Discuss cardiac history, liver function and concomitant medicines with the prescriber.

• Absolute Contraindications:
  • Hypersensitivity to citalopram or other SSRIs.
  • Concurrent use with monoamine oxidase inhibitors (MAOIs) or within 2 weeks of MAOI stop.
  • Use with pimozide or other drugs known to prolong the QT interval.

Elderly patients (aged 65 or over) and those with hepatic impairment should normally be limited to a maximum of 20 mg per day because of QT prolongation risk.

Pregnant or breastfeeding patients require a careful risk–benefit discussion and liaison with obstetric mental-health services following MHRA and NICE guidance.

For patients with chronic illness such as unstable cardiac disease, recent myocardial infarction or severe liver disease, specialist review is recommended.

Do not start citalopram until the prescriber and pharmacist have reviewed risks and discussed monitoring.

Pre-Prescription Safety Screen (Checklist)

1. Record baseline ECG if history of cardiac disease or taking other QT‑prolonging drugs.
2. Review current medicines and over-the-counter supplements for interactions.
3. Check electrolytes if patient is on diuretics, has vomiting or diarrhoea, or heart disease.
4. Assess hepatic and renal function where indicated.
5. Confirm pregnancy and breastfeeding status; document discussion with maternity team if required.

Interaction With Activities (Driving, Workplace Safety Under UK Law)

Can citalopram affect driving or UK workplace safety?

Citalopram can cause dizziness, somnolence and blurred vision, especially during initiation or dose changes.

Advise patients not to drive or operate heavy machinery until they know how the medicine affects them.

Record the driving/workplace safety advice in the patient medication record (PMR) at each supply.

Advise employers where appropriate if treatment may affect the employee’s ability to perform safety-critical tasks.

Q&A — “Can I Drive After Taking It In The UK?”

Q: Can I drive after taking citalopram?

A: There is no definitive legal ban on driving after taking citalopram, but if you feel drowsy, dizzy or slowed, do not drive.

• Road Traffic Act Duties: Drivers must not be impaired by a medicine when driving and must follow DVLA guidance on medical fitness to drive.
• Employer Safety Policies: Many employers require staff in safety-critical roles to declare medicines that could impair performance; follow company policy.
• Document Advice: Note the discussion in the PMR and suggest a trial of the medicine at home to assess effects before resuming driving.

Usage Basics

INN, Brand Names Available In The UK

What names will you see on a prescription or packet?

The INN is citalopram.

Common UK brands include Cipramil, Citalopram Teva and Sandoz tablets, and branded or generic oral drops supplied by several manufacturers.

• Cipramil
• Citalopram Teva
• Sandoz
• Generic presentations labelled as citalopram tablets or oral solution

Legal Classification (POM, P, GSL)

Is citalopram available without a prescription in the UK?

Citalopram is a Prescription‑Only Medicine (POM) in the UK and is not available over the counter.

Prescriptions may be issued via NHS electronic prescribing services or a private prescription when appropriate.

Pharmacist counselling is mandatory at supply and should be recorded.

Dispensing Documentation Checklist

1. Valid prescription (FP10, EPS token or private script).
2. Patient identity verification where required for online supply.
3. Allergy status recorded.
4. Medication history and interaction check completed.
5. PMR entry with counselling and follow-up date.

Dosing Guide

Standard Regimens (NHS Guidelines)

How is citalopram usually started and adjusted?

For major depressive disorder, a typical adult start is 20 mg once daily, with a maximum of 40 mg per day for most adults.

For panic disorder and social phobia, start at 10 mg once daily and increase as tolerated to 20–40 mg once daily.

Elderly patients (≥65 years) and those with hepatic impairment generally have a maximum recommended dose of 20 mg per day because of QT prolongation risk.

Choose once‑daily dosing in the morning or evening depending on tolerability.

Allow 1–4 weeks to notice improvement and continue treatment for at least six months after remission in MDD unless otherwise advised by the prescriber.

Adjustments For Comorbidities

How should dosing change with other health problems?

Start with a lower dose in patients with hepatic or significant renal impairment and increase only if necessary and tolerated.

Avoid use in severe hepatic impairment unless strictly necessary and under specialist care.

Review concomitant drugs that may increase plasma levels or prolong QT interval and adjust dose or choose an alternative where required.

Q&A — “What If I Miss A Dose?”

Q: What if I miss a dose of citalopram?

A: Take the missed dose as soon as you remember unless the next scheduled dose is due soon.

Do not double up doses to make up for missed tablets.

If you stop treatment, taper under clinical supervision to reduce the risk of withdrawal symptoms.

1. Typical taper: reduce dose gradually over weeks to months depending on duration of use and clinical judgement.
2. Short courses may be tapered more quickly than long-term treatment.
3. Contact the prescriber or pharmacist for a personalised taper schedule.

Interaction Chart

Food And Drinks (Alcohol, Tea/Coffee, Diet Habits)

Are there food or drink restrictions with citalopram?

Alcohol can increase sedation and may worsen depression, so counsel patients to reduce or avoid alcohol while taking citalopram.

Caffeine from tea and coffee may aggravate anxiety or insomnia in sensitive patients.

There are no specific food restrictions, but monitor for appetite and weight changes and advise a balanced diet.

• Alcohol: reduce or avoid while taking citalopram to lessen sedation and mood effects.
• Caffeine: monitor intake if patients report increased anxiety or insomnia.
• Diet: encourage balanced nutrition and monitoring of weight and appetite.

Common Drug Conflicts (MHRA Yellow Card Data)

Which medicines interact importantly with citalopram?

Key interacting groups include MAOIs, other serotonergic medicines, antiplatelet and NSAID drugs, QT‑prolonging medicines, and CYP enzyme inhibitors.

Avoid combining citalopram with pimozide or other known QT‑prolonging drugs.

Consider ECG monitoring when combining with drugs that increase QT risk or when doses approach higher limits.

Carry out medication reconciliation at each review to identify interactions and document action taken.

User Reports & Trends

What do UK patients commonly say about citalopram online?

Patient-reported outcomes from NHS Choices, Patient.info and UK forums often highlight similar early experiences and concerns.

• Common early side effects reported include nausea and sleep disturbance.
• Sexual dysfunction and emotional blunting are frequently mentioned as moderate concerns.
• Withdrawal or discontinuation symptoms are reported when treatment is stopped abruptly.
• Many patients note perceived benefit after two to four weeks of treatment.

Self-reports vary widely and can reflect placebo effects or individual differences in tolerability.

Examples of anonymised, fictionalised patient comments used for tone only:

• “I felt sick for a few days, then things started to lift after three weeks.”
• “My libido changed and I spoke to my GP about switching.”

Encourage reporting of adverse events via the MHRA Yellow Card scheme and ensure counselling and any adverse events are recorded in pharmacy records.

Access & Purchase Options

Boots, LloydsPharmacy, Superdrug

How can patients obtain citalopram in the UK?

Typical NHS and private supply routes are via a GP-issued NHS prescription or a private prescription.

Community pharmacies such as Boots, LloydsPharmacy, Superdrug and independent pharmacies dispense citalopram and often provide delivery or collection services.

In our online pharmacy, citalopram is available without a prescription, with discreet delivery to United Kingdom in 5-14 days.

Online Pharmacies And NHS E-Prescriptions

What should patients check when ordering online?

Use MHRA-registered online pharmacies and ensure the pharmacy is registered with the General Pharmaceutical Council.

Pharmacist verification of identity and provision of counselling before supply is essential for POM medicines.

Safe Online Purchase Checklist

1. Confirm GPhC registration and MHRA-compliant online pharmacy status.
2. Ensure a secure electronic prescription or accepted private prescription.
3. Verify pharmacist counselling is available by phone or video.
4. Check patient identity procedures and data security measures.

Mechanism & Pharmacology

Simplified Explanation

How does citalopram work in the brain?

Citalopram is a selective serotonin reuptake inhibitor (SSRI) with ATC code N06AB04.

It increases synaptic serotonin by inhibiting reuptake at the serotonin transporter.

Over several weeks, downstream adaptive changes in receptors and signalling are associated with mood improvement.

Pharmacokinetics differ between oral tablets and drops, and the medicine is metabolised hepatically, so monitor use in liver impairment.

For patient leaflets, use a simple flow diagram: serotonin synapse → reuptake inhibition → increased serotonin in the synaptic cleft → adaptive neuronal changes → improved mood over weeks.

Clinical Terms

What do key terms mean?

• SSRI: Selective serotonin reuptake inhibitor, a class of antidepressant.
• Onset: Initial effects often seen in 1–4 weeks, with full effect taking longer.
• Steady State: The plasma concentration reached after a few days of once‑daily dosing.
• Half‑Life: Influences tapering schedules and time to clear from the body.
• QT Prolongation: A cardiac electrical change that can increase arrhythmia risk; dose limits apply to reduce risk.
• Serotonin Syndrome: A potentially serious reaction from too much serotonergic activity when citalopram is combined with other serotonergic agents.

Indications & Off-Label Uses

MHRA-Approved Uses

For which conditions is citalopram licensed?

Citalopram is approved for major depressive disorder and is used for anxiety disorders including panic disorder and social phobia according to product summaries and NHS pathways.

Dosing varies by indication; for MDD the common initial dose is 20 mg once daily.

Off-Label Practices In NHS And Private Care

Are there off-label uses in the NHS or private practice?

Occasional off-label prescribing may include neuropathic pain or premature ejaculation in selected cases, but this requires documented rationale and informed consent.

Specialist psychiatric input is recommended for paediatric or complex cases.

Key Clinical Findings

What do recent UK and EU studies say about citalopram and SSRIs?

SSRIs including citalopram show modest superiority to placebo for moderate to severe major depressive disorder in meta-analyses and trials.

Head‑to‑head data often favour individualised choice based on tolerability and side‑effect profiles rather than a single superior drug.

Safety alerts about QT prolongation have informed dose limits in older adults and those with cardiac risk factors.

• Prioritise tolerability, drug interactions and comorbidities when choosing an SSRI.
• Review up-to-date MHRA and NICE guidance for specific trial results and safety communications.
• Consider ECG monitoring in patients with cardiac risk or when combining QT‑prolonging drugs.

Suggested reading for clinicians: NICE depression guidance, MHRA safety updates and Cochrane reviews on SSRIs.

Alternatives Matrix

NHS Prescribing Alternatives (Comparison Table)

Pros And Cons Checklist

1. Review prior response to antidepressants.
2. Assess side-effect burden and patient preference.
3. Check drug interactions and cardiac history (QT risk).
4. Consider pregnancy plans and contraception status.
5. Decide on cross‑tapering versus abrupt switch with specialist input as needed and per NICE guidance.

Common Questions (Patient-Facing FAQ)

Patients often ask the same practical questions when starting citalopram.

• How Long Until It Works? Initial improvement often in 1–4 weeks, with fuller effect up to 6–8 weeks for some patients.
• Sexual Side Effects are common; management includes dose adjustment, switching to another antidepressant, or adding treatments under specialist advice.
• Withdrawal Symptoms can occur if stopped abruptly; gradual taper under clinical supervision is important.
• Pregnancy And Breastfeeding require discussion with the prescriber and the maternity or perinatal mental health team before starting or continuing treatment.

Decision flowchart for urgent action: contact GP for worsening mood or intolerable side effects; seek A&E for signs of serotonin syndrome, severe chest pain or suspected arrhythmia.

Report side effects to the MHRA Yellow Card scheme and keep pharmacy records up to date for continuity of care.

NHS Cost & Access Comparison Table

How do prices and charges vary across the UK?

Prescription charges apply in England unless exempt, while Scotland, Wales and Northern Ireland generally provide prescriptions free of charge.

Do not quote fixed prescription charges; check current NHS websites for up-to-date tariffs.

Prescription Exemption Checklist

• Age-related exemptions (children, older adults in some schemes).
• Low-income or means-tested benefits where applicable.
• Certain medical conditions may confer exemption.

Advise patients about repeat prescriptions, FP10, Electronic Prescription Service (EPS) and NHS Patient Access apps to manage requests and repeats.

Registration & Regulation

MHRA Approval Process

How is citalopram regulated in the UK?

Citalopram is authorised by MHRA/EMA for indicated uses and is subject to post-market surveillance and occasional safety communications such as QT warnings.

• Marketing Authorisation: Licence granted following regulatory review.
• Yellow Card: Pharmacovigilance reporting system for adverse events.
• PSUR: Periodic safety update reports submitted by the marketing authorisation holder.

NHS Prescribing Framework

Prescribing should follow NICE guidance, local formularies and shared-care agreements where present.

Document informed consent and rationale for off‑label use clearly in records.

Prescriber Record-Keeping Checklist

1. Indication and intended duration of therapy.
2. Starting dose and planned review date.
3. Monitoring plan for side effects and interactions.
4. Consent and discussion notes for pregnancy or off-label use.

Storage & Handling

UK Household Storage (Cold/Damp Climate)

How should patients store citalopram at home?

Store below 25°C and protect from light and moisture.

Keep tablets in their original blister pack until use and close bottles tightly for oral solution.

Avoid storing medicines in bathrooms or near radiators where humidity and temperature fluctuations are common.

• Keep medicines out of reach of children and pets, preferably in a locked cabinet.
• Do not expose bottles to freezing conditions during cold UK weather or to direct sunlight.
• Carry a small quantity in original packaging when travelling and keep the prescription or a copy with you.

Traveller Checklist

1. Carry original packaging with labels.
2. Bring a copy of the prescription or a prescriber letter if travelling abroad.
3. Avoid leaving medicines in hot cars or luggage in high heat.

Guidance From NHS And Pharmacists

Dispose of unwanted or expired citalopram via pharmacy return schemes and do not flush medicines down the toilet.

Community pharmacies should store stock per SOPs in clearly labelled containers and check expiry dates regularly.

Guidelines For Proper Use

UK Pharmacist Counselling Style

What should the pharmacist say at supply?

Use a clear, scripted counselling approach covering name/INN (citalopram), indication, dose and expected onset.

Explain common side effects and warning signs such as increased suicidal thoughts, serotonin syndrome or cardiac symptoms.

Give driving and workplace advice and explain how to report side effects via the MHRA Yellow Card.

Use teach-back to confirm understanding and document the counselling in the PMR.

• Confirm allergies and pregnancy status before supply.
• Check concomitant medicines and ECG history where indicated.
• Agree a review timeline with the patient.

NHS Patient Safety Advice

Set clear review timelines: contact within 1–2 weeks for side-effect checks and 4–6 weeks for efficacy review.

Document informed consent and a gradual taper plan for when treatment is to be stopped.

Refer to IAPT or psychiatry for non-response, complex cases or severe adverse events.

Flag ECG monitoring where QT risk factors are present and ensure regular medication reviews are scheduled.

Delivery Across United Kingdom

Closing Notes For Patients And Clinicians

Summary points for safe use of citalopram in the UK are straightforward and evidence based.

Citalopram is an SSRI available as 10 mg, 20 mg and 40 mg tablets and as an oral solution of 10 mg/mL and 20 mg/mL.

It is a prescription-only medicine and requires pharmacist counselling at each supply.

Elderly patients and those with hepatic impairment should normally be limited to 20 mg per day because of QT risk.

Avoid combinations with MAOIs and pimozide, monitor for serotonin syndrome with other serotonergic drugs, and consider ECG monitoring for patients with cardiac risk.

Encourage adverse-event reporting through the MHRA Yellow Card scheme and document all counselling and safety checks in the PMR.

For questions about switching, tapering or pregnancy-related decisions, liaise with the prescriber and specialist services as needed.